Iqvia Holdings Inc
Change company Symbol lookup
Select an option...
IQV Iqvia Holdings Inc
EVRG Evergy Inc
TTWO Take-Two Interactive Software Inc
CLVS Clovis Oncology Inc
VNCE Vince Holding Corp
CREE Cree Inc
NDSN Nordson Corp
CIEN Ciena Corp
FTSV Forty Seven Inc
KZR Kezar Life Sciences Inc

Health Care : Life Sciences Tools & Services | Large Cap BlendCompany profile

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Apple stock falls after HSBC downgrade

8:24 am ET December 4, 2018 (MarketWatch)

Apple Inc. (AAPL) shares are down 2.1% in premarket trading Tuesday after HSBC analyst Erwan Rambourg downgraded the stock to hold from buy, writing that it was "too late to sell, too early to buy" Apple shares, which have fallen 19% over the past three months. "Apple has to innovate to ensure that the installed hardware base doesn't shrink," wrote Rambourg, who suggested three "complementary strategies" for the company. One is "horizontal diversification and geographic expansion," as services like Apple Pay are growing fast but could benefit from more reach, in Rambourg's view. Another approach would be adding new services and applications in areas such as augmented reality that would drive hardware improvement and excite current iPhone users. Rambourg's final strategy is "pure innovation" in new realms like autonomous driving, health, and augmented-reality glasses. He lowered his price target to $200 from $205, writing of an "undemanding valuation" but limited "immediate catalysts." The shares are down 11% over the past month, while the Dow Jones Industrial Average has risen 2.2%.

-Emily Bary; 415-439-6400;

(END) Dow Jones Newswires

December 04, 2018 08:24 ET (13:24 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.